Press Release
ScalePad Announces Free GRC Platform Built for MSPs
New ControlMap Free and Essentials tiers remove the cost and complexity barriers to delivering compliance as a core service, making it easier to start every client on a path to stronger risk management, trust, and long-term growth. Read More
Press Release
Dr. Peter Talisse Joins Ankle & Foot Centers of America, Serving Peachtree City, Newnan, and Fayetteville
A fellowship-trained foot and ankle surgeon with expertise in reconstruction, sports injuries, and limb salvage, Dr. Talisse brings advanced care to three South Metro Atlanta locations. Read More
Press Release
NextTrip Acquires TA Pipeline, LLC to Expand Group Travel Platform with Immediate Revenue Contribution and Scalable Growth Opportunity
Acquisition Enhances Premier Resort Network Across the Caribbean and Mexico, Automates Group Travel, and Positions Platform for Accelerated Ramp Through NextTrip Integration Read More
Press Release
IGC Pharma Highlights Alzheimer's Pipeline with Encouraging Preclinical Data on IGC-M3 and Advancing Phase 2 Cannabinoid-Based IGC-AD1
Positions IGC at the intersection of biotech innovation and cannabinoid science in one of the largest unmet medical needs in the world Alzheimer's affects over 50 million people globally, with more than 400 million at risk from underlying disease pathology Read More
Press Release
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates
Click here to register Company plans to file its Earnings Report on August 14, 2025 on Form 10-Q for the quarter ended June 30, 2025 Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to register Read More
Press Release
'Like GoFundMe and Facebook Marketplace Had a Baby': ReRaiseIt Changes the Way We Fundraise
ReRaiseIt Launches a Transparent, Community-Driven Platform That Combines Fundraising With Sustainable Resale, Empowering Individuals and Organizations to Turn Unused Items Into Real-World Impact Through Commerce-Integrated Giving Read More
Press Release
MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin
Manuscript accepted for publication in Frontiers in Pharmacology, "Oral Administration of Ketamir-2, a Novel Ketamine Analog, Attenuates Neuropathic Pain in Rodent Models via Selective NMDA Antagonism" details Ketamir-2's superior performance in two validated neuropathic pain models and supports advancement to Phase 2a clinical trials by year-end 2025. Read More
Press Release
ACCESS Newswire Reports Second Quarter 2025 Results
Operational Efficiencies Improve, Increasing EBITDA and Cash Flow Revenue increased 3% to $5.6M compared to $5.5M in Q1 2025 and decreased 7% from $6.0M in Q2 2024 Adjusted EBITDA increased $308,000 to $836,000 compared to $528,000 in Q2 2024 The Company was cash flow positive for the quarter, with cash flow from operations increasing $325,000 from Q2 2024 Subscriptions increased to 971 at the end of Q2 2025 from 955 at the end of Q1 2025 and 867 in Q2 2024 Read More
Press Release